Tiny Zymeworks Snags $1.4B+ R&D Deal With Drug Giant Johnson & Johnson Post author:Sam Post published:November 12, 2017 Post category:BioPharma There’s nothing like a billion-plus dollar deal to make investors happy on a Monday. Source: BioSpace You Might Also Like Avita Medical Taps Investors for A$16.9 Million to Commercialise Its 'Spray-On Skin' October 10, 2017 InVivo Therapeutics Announces Seventh Patient Conversion In The INSPIRE Study Of The Neuro-Spinal Scaffold March 27, 2017 Novartis AG Lays Out R&D Game Plan at Meet and Greet With 30 Execs in Boston May 31, 2017
Avita Medical Taps Investors for A$16.9 Million to Commercialise Its 'Spray-On Skin' October 10, 2017
InVivo Therapeutics Announces Seventh Patient Conversion In The INSPIRE Study Of The Neuro-Spinal Scaffold March 27, 2017
